Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines

[1]  H. Lodish,et al.  Fetal Anemia and Apoptosis of Red Cell Progenitors in Stat5a−/−5b−/− Mice A Direct Role for Stat5 in Bcl-XL Induction , 1999, Cell.

[2]  F. Gouilleux,et al.  IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line , 1999, Oncogene.

[3]  H. Broxmeyer,et al.  Flt3 signaling involves tyrosyl‐phosphorylation of SHP‐2 and SHIP and their association with Grb2 and Shc in Baf3/Flt3 cells , 1999, Journal of leukocyte biology.

[4]  Itaru Matsumura,et al.  Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine‐dependent growth of hematopoietic cells , 1999, The EMBO journal.

[5]  H. Saito,et al.  Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product , 1998, Leukemia.

[6]  D. Birnbaum,et al.  The CBL-related Protein CBLB Participates in FLT3 and Interleukin-7 Receptor Signal Transduction in Pro-B Cells* , 1998, The Journal of Biological Chemistry.

[7]  T. Naoe,et al.  Differential constitutive activation between STAT‐related proteins and MAP kinase in primary acute myelogenous leukaemia , 1998, British journal of haematology.

[8]  D. Birnbaum,et al.  FLT3 signaling in hematopoietic cells involves CBL, SHC and an unknown P115 as prominent tyrosine-phosphorylated substrates , 1998, Leukemia.

[9]  Lena Claesson-Welsh,et al.  Activation of Stat5 by platelet-derived growth factor (PDGF) is dependent on phosphorylation sites in PDGF β-receptor juxtamembrane and kinase insert domains , 1998, Oncogene.

[10]  T. Naoe,et al.  Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines , 1997, Leukemia.

[11]  M. Taniwaki,et al.  Tandem duplications of the FLT3 receptor gene are associated with leukemic transformation of myelodysplasia , 1997, Leukemia.

[12]  H. Saito,et al.  Constitutive activation of mitogen-activated protein kinase pathway in acute leukemia cells , 1997, Leukemia.

[13]  Z. Estrov,et al.  Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: regulation of Bcl-2 and Bax. , 1996, Blood.

[14]  A. Miyajima,et al.  Suppression of interleukin‐3‐induced gene expression by a C‐terminal truncated Stat5: role of Stat5 in proliferation. , 1996, The EMBO journal.

[15]  M. Collins,et al.  The role of MAP kinase kinase in interleukin-3 stimulation of proliferation. , 1996, Blood.

[16]  M. Vignais,et al.  Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins , 1996, Molecular and cellular biology.

[17]  D. Hirschstein,et al.  Effects of flt3 ligand on acute myeloid and lymphocytic leukemic blast cells from children. , 1996, Experimental hematology.

[18]  M. Brizzi,et al.  Effects of human FLT3 ligand on myeloid leukemia cell growth: heterogeneity in response and synergy with other hematopoietic growth factors. , 1995, Blood.

[19]  J. Darnell,et al.  Maximal activation of transcription by statl and stat3 requires both tyrosine and serine phosphorylation , 1995, Cell.

[20]  S. Goff,et al.  Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. , 1995, Immunity.

[21]  A. Saltiel,et al.  Inhibition of MAP Kinase Kinase Blocks the Differentiation of PC-12 Cells Induced by Nerve Growth Factor(*) , 1995, The Journal of Biological Chemistry.

[22]  B. Groner,et al.  Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. , 1994, The EMBO journal.

[23]  I. Lemischka,et al.  Mitogenic signalling and substrate specificity of the Flk2/Flt3 receptor tyrosine kinase in fibroblasts and interleukin 3-dependent hematopoietic cells , 1993, Molecular and cellular biology.

[24]  G. Gill,et al.  Receptor tyrosine kinases , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  D. Pardoll,et al.  A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations , 1991, Cell.

[26]  D. Birnbaum,et al.  Isolation and chromosomal localization of a novel FMS-like tyrosine kinase gene. , 1991, Genomics.

[27]  A. Ullrich,et al.  Growth factor receptor tyrosine kinases. , 1988, Annual review of biochemistry.